Click a link below to view the mailing archive as if it had been sent to you.
| 2025-03-31 12:15 | | Pharma stocks sink after ouster of top FDA vaccine regulator and more... |
| 2025-03-31 00:15 | | FDA broadens use of Novartis’ radiopharma drug Pluvicto and more... |
| 2025-03-28 12:15 | | Senate investigation claims Pfizer shifted profits offshore in what could be pharma's 'largest tax-dodging scheme' and more... |
| 2025-03-28 00:15 | | Trump tariff threats prompt some drugmakers to expedite shipments to US and more... |
| 2025-03-27 12:15 | | RFK Jr. prepares 10,000 more job cuts across HHS, outlines office consolidations and more... |
| 2025-03-27 00:15 | | J&J combo signals new era in EGFR lung cancer with survival win against AstraZeneca's Tagrisso and more... |
| 2025-03-26 12:15 | | Trump turbulence stalls large pharma and biotech deals, bankers say and more... |
| 2025-03-26 00:15 | | GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa and more... |
| 2025-03-25 12:15 | | GSK builds on real-world experiment to study Shingrix’s impact on dementia and more... |
| 2025-03-24 12:15 | | Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks and more... |
| 2025-03-24 00:15 | | Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won and more... |
| 2025-03-21 12:15 | | Gene therapy loses luster as investors eye quicker returns from weight-loss drugs and more... |
| 2025-03-21 00:15 | | Alnylam drug gets long-awaited FDA approval in deadly heart disease and more... |
| 2025-03-20 12:15 | | Sanofi to acquire Dren Bio’s immunology unit and more... |
| 2025-03-20 00:15 | | Some FDA staff considering quitting due to Trump’s RTO policy and more... |
| 2025-03-19 12:15 | | Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon and more... |
| 2025-03-19 00:15 | | Prime sets sights on liver, lung disease as next target for its gene editing tech and more... |
| 2025-03-18 12:15 | | Duchenne patient dies after receiving Sarepta gene therapy and more... |
| 2025-03-18 00:15 | | FDA’s return-to-office chaos, probationary workers reinstated, and demotion fears and more... |
| 2025-03-17 12:15 | | AstraZeneca makes potential $1B cell therapy play in EsoBiotec buy and more... |
| 2025-03-17 00:15 | | Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season and more... |
| 2025-03-15 00:15 | | In rebound year for Pfizer, CEO Albert Bourla scored 14% total pay increase to $24.6M |
| 2025-03-14 12:15 | | Altimmune to test obesity drug for alcohol use disorder and related health conditions and more... |
| 2025-03-14 00:15 | | Houston’s life sciences scene continues boosting its reputation and more... |
| 2025-03-13 12:15 | | Lilly, J&J boosted spending on executive security after UnitedHealth shooting and more... |
| 2025-03-13 00:15 | | Mallinckrodt, Endo near $7B merger: report and more... |
| 2025-03-12 12:15 | | Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024 and more... |
| 2025-03-12 00:15 | | A once-yearly PrEP? Gilead's lenacapavir shows promise as company plots phase 3 and more... |
| 2025-03-11 12:15 | | 2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M and more... |
| 2025-03-11 00:15 | | Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment and more... |
| 2025-03-10 12:15 | | On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M and more... |
| 2025-03-07 12:15 | | J&J axes late-stage depression trial after underwhelming efficacy and more... |
| 2025-03-07 00:15 | | Novo Nordisk to explore how GLP-1 drugs can help patients with addiction and more... |
| 2025-03-06 12:15 | | 'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen and more... |
| 2025-03-06 00:15 | | Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck and more... |
| 2025-03-05 12:15 | | Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients and more... |
| 2025-03-04 12:15 | | Roche continues regulatory run with acute stroke expansion for heart attack drug and more... |
| 2025-03-04 00:15 | | Lexicon’s non-opioid therapy for DPNP beats placebo in pain reduction and more... |
| 2025-03-03 12:15 | | AbbVie pays Gubra $350M to make late play for obesity space and more... |
| 2025-03-03 00:15 | | FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers and more... |
